FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

41346911000001107: Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Jan 2023. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2504821000001114 Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2504841000001116 Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose Is a Salbutamol 1mg/ml nebuliser liquid 2.5ml unit dose vials 20 unit dose true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose Has AMP Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salbutamol true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose Has dispensed dose form Nebuliser liquid true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Brodilaten 2.5mg/2.5ml nebuliser solution unit dose ampoules (Kent Pharma (UK) Ltd) 20 unit dose Has specific active ingredient Salbutamol sulfate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start